Skip to main content

Aurora Cannabis Inc.

corporate_fare Company Profile

Aurora Cannabis Inc.

ACB·NASDAQ·Life Sciences·CIK 0001683541

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. The company operates through two segments: Canadian Cannabis and Plant Propagation. It offers pharmaceutical-grade cannabis products, medical and consumer cannabis products, and engages in the propagation of vegetables and floral plants. Its product offerings include dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals. Aurora Cannabis Inc. also provides patient counseling and outreach services. The company's brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC. Its international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc. (NASDAQ:ACB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 36 items for ACB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Aurora Cannabis Forms Special Committee in Response to Curaleaf's Hostile Bid
  • Curaleaf Launches Hostile $4/Share Bid for Aurora Cannabis, 45% Premium
  • Aurora Cannabis Q1 FY27: International Medical Revenue Jumps 17%, Adjusted EBITDA Falls to C$3.4M
  • Aurora Cannabis Q1 FY27: Net Loss Narrows, Material Weakness Persists, $46M Cash Unlock Ahead
  • Aurora Cannabis Flags Fresh Internal Control Weakness Over Biological Assets and Inventory

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
CA$320.59M CAD
Net Income
-CA$135.96M CAD
Diluted EPS
-CA$2.14 CAD
Op. Cash Flow
-CA$13.51M CAD
Free Cash Flow
-CA$36.06M CAD
Gross Profit
CA$136.65M CAD
Cash & Equivalents
CA$64.69M CAD
Total Debt
CA$0 CAD
Debt / Equity
0.00×
Net Margin
-42.4%
Shares Outstanding
58.95M sh
Source: 40-F · filed 2026-06-11 · accession 0001628280-26-042364

Insider Transactions

ACB files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

$3.98 -1.97% today
52-week range · as of 2026-10-26 $2.56 – $6.36
Market cap
$266.92M
Volume
807.1K (0.8× avg)
3-mo avg 1M
Live data · 2026-11-01 04:21 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ACB - Filings & News (Page 2)

ACB
Aug 11, 2026, 3:43 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.49
Real-time Price: $3.98 info
Change: +$0.495 (+14%) info
Market Cap: $266.924M info
ACB
Aug 11, 2026, 8:25 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $3.02
Real-time Price: $3.98 info
Change: +$0.960 (+32%) info
Market Cap: $266.924M info
ACB
Aug 05, 2026, 7:46 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.85
Real-time Price: $3.98 info
Change: +$1.13 (+40%) info
Market Cap: $266.924M info
ACB
Aug 05, 2026, 7:05 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.85
Real-time Price: $3.98 info
Change: +$1.13 (+40%) info
Market Cap: $266.924M info
ACB
Jul 08, 2026, 5:45 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.68
Real-time Price: $3.98 info
Change: +$1.30 (+49%) info
Market Cap: $266.924M info
ACB
Jun 11, 2026, 7:33 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.92
Real-time Price: $3.98 info
Change: +$1.07 (+37%) info
Market Cap: $266.924M info
ACB
Jun 11, 2026, 7:05 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $3.21
Real-time Price: $3.98 info
Change: +$0.7681 (+24%) info
Market Cap: $266.924M info
ACB
Jun 11, 2026, 7:04 AM EDT
Filing Type: 40-F
Importance Score:
9
Price at Filing: $2.91
Real-time Price: $3.98 info
Change: +$1.08 (+37%) info
Market Cap: $266.924M info
ACB
May 14, 2026, 8:44 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.33
Real-time Price: $3.98 info
Change: +$0.650 (+20%) info
Market Cap: $266.924M info
ACB
Apr 28, 2026, 8:15 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $3.43
Real-time Price: $3.98 info
Change: +$0.550 (+16%) info
Market Cap: $266.924M info
ACB
Apr 15, 2026, 7:21 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.53
Real-time Price: $3.98 info
Change: +$0.450 (+13%) info
Market Cap: $266.924M info
ACB
Feb 12, 2026, 4:26 PM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.36
Real-time Price: $3.98 info
Change: +$0.6185 (+18%) info
Market Cap: $266.924M info
ACB
Feb 04, 2026, 4:44 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $3.79
Real-time Price: $3.98 info
Change: +$0.190 (+5%) info
Market Cap: $266.924M info
ACB
Feb 04, 2026, 7:27 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.04
Real-time Price: $3.98 info
Change: -$0.060 (-1%) info
Market Cap: $266.924M info
ACB
Feb 04, 2026, 7:05 AM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.04
Real-time Price: $3.98 info
Change: -$0.060 (-1%) info
Market Cap: $266.924M info
ACB
Jan 14, 2026, 7:22 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.23
Real-time Price: $3.98 info
Change: -$0.245 (-6%) info
Market Cap: $266.924M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets